Literature DB >> 21520774

Present and future tense in operable rectal cancer.

F Popa1, M Bratucu, P Radu.   

Abstract

In the last three decades it has been repeatedly insisted on the total mesorectal excision (TME), as being the key for pelvic recurrence. The authors have focused upon issues still "questionable", that invite reflection, having as a starting point now become the classic precepts of RJ Heald. The authors stop mainly on defining points that justify the complex therapeutical approach of rectal cancer. There are discussed some issues still subject to controversy: the extent of regional extirpation, critical points of surgical risk, the attitude towards the protection of genito-urinary innervation. In this purpose surgical considerations are presented on: the anatomy of the rectum and mesorectum, TME and its limits, on dissemination issues and pathology tumor grading, pelvic relapse and the place of adjuvant therapy. Complication rate is also analyzed and the quality of life of patients undergoing TME. Finally conclusions are advanced, some of them having the capacity to provide topics for future study and debate.

Entities:  

Mesh:

Year:  2011        PMID: 21520774

Source DB:  PubMed          Journal:  Chirurgia (Bucur)        ISSN: 1221-9118


  9 in total

1.  CHD1L is a novel independent prognostic factor for gastric cancer.

Authors:  Z Su; J Zhao; G Xian; W Geng; Z Rong; Y Wu; C Qin
Journal:  Clin Transl Oncol       Date:  2013-11-21       Impact factor: 3.405

2.  CorRECTreatment: a web-based decision support tool for rectal cancer treatment that uses the analytic hierarchy process and decision tree.

Authors:  A Suner; G Karakülah; O Dicle; S Sökmen; C C Çelikoğlu
Journal:  Appl Clin Inform       Date:  2015-02-04       Impact factor: 2.342

3.  T-box 2 expression predicts poor prognosis in gastric cancer.

Authors:  Haihua Yu; B O Liu; Aiwu Liu; Kai Li; Hongpeng Zhao
Journal:  Oncol Lett       Date:  2015-06-26       Impact factor: 2.967

4.  High expression of peroxiredoxin 4 affects the survival time of colorectal cancer patients, but is not an independent unfavorable prognostic factor.

Authors:  Nan Yi; Ming Bing Xiao; Wen Kai Ni; Feng Jiang; Cui Hua Lu; Run-Zhou Ni
Journal:  Mol Clin Oncol       Date:  2014-06-16

5.  Expression of tumor necrosis factor α-induced protein 8 is upregulated in human gastric cancer and regulates cell proliferation, invasion and migration.

Authors:  Yansen Li; Changqing Jing; Yuezhi Chen; Jinshen Wang; Mingliang Zhou; Xin Liu; Dong Sun; Linjun Mu; Leping Li; Xiaobo Guo
Journal:  Mol Med Rep       Date:  2015-04-27       Impact factor: 2.952

6.  MicroRNA-200b-3p restrains gastric cancer cell proliferation, migration, and invasion via C-X-C motif chemokine ligand 12/CXC chemokine receptor 7 axis.

Authors:  Dinuo Li; Qiang Li
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

7.  The metastasis suppressor, N-myc downregulated gene 1 (NDRG1), is a prognostic biomarker for human colorectal cancer.

Authors:  Zhihai Mao; Jing Sun; Bo Feng; Junjun Ma; Lu Zang; Feng Dong; Daohai Zhang; Minhua Zheng
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

8.  Abnormal expression of calcyphosine is associated with poor prognosis and cell biology function in colorectal cancer.

Authors:  Weiwei Shao; Quhui Wang; Feiran Wang; Yasu Jiang; Meirong Xu; Junfei Xu
Journal:  Onco Targets Ther       Date:  2016-01-25       Impact factor: 4.147

9.  Over-expression of ARHGAP18 suppressed cell proliferation, migration, invasion, and tumor growth in gastric cancer by restraining over-activation of MAPK signaling pathways.

Authors:  Yan Li; Shan Ji; Liye Fu; Tao Jiang; Di Wu; Fandong Meng
Journal:  Onco Targets Ther       Date:  2018-01-09       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.